Engineers Gate Manager’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
Other funds holding PRME
AI
AIM
VCM
CC
WP
Engineers Gate Manager's PRME Position: Q1 2026 in Review
Engineers Gate Manager increased its Prime Medicine (PRME) stake by 82% in Q1 2026, buying an estimated $190K and bringing the position to 110,348 shares worth $384K. The position accounts for ﹤0.01% of the portfolio, ranked #1566.
Engineers Gate Manager first reported a position in PRME in Q3 2025 and has held it in 3 quarters since. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.
- Engineers Gate Manager held 110,348 shares of Prime Medicine worth $384K as of Q1 2026.
- Engineers Gate Manager bought 49,858 Prime Medicine shares in Q1 2026, an estimated $190K.
- Prime Medicine made up ﹤0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1566 holding.
- Engineers Gate Manager first reported a position in Prime Medicine in Q3 2025 and has held it in 3 quarters since.
- 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.
Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.